Ask Warren

Aribio Holdings

290690 · KOSDAQ · ₩290690 · 아리바이오홀딩스

₩2,620▼ ₩65 (2.42%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩11B₩7.4B₩15B₩7.9B₩9.8B₩5.1B₩9.9B₩16B
Cost of sales₩8.9B₩6.8B₩14B₩6.2B₩8.7B₩4.8B₩8.7B₩14B
Gross profit₩1.7B₩593M₩1.2B₩1.7B₩1B₩375M₩1.2B₩2.1B
Operating income−₩2.8B−₩3.1B₩342M−₩2.4B−₩2.8B−₩1.8B−₩1.9B−₩813M
Net income₩11B−₩8.5B₩18B−₩7.1B−₩14B−₩4.9B−₩31B−₩2.4B
Net income to shareholders₩11B−₩8.5B₩18B−₩7.1B−₩14B−₩4.9B−₩31B−₩2.4B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩196B₩155B₩142B₩110B₩113B₩128B₩117B₩148B
Current assets₩38B₩38B₩19B₩24B₩24B₩34B₩25B₩26B
Cash and equivalents₩9.5B₩4B₩628M₩836M₩1.3B₩788M₩3.2B₩765M
Total liabilities₩83B₩70B₩51B₩45B₩43B₩39B₩39B₩54B
Current liabilities₩76B₩64B₩45B₩44B₩42B₩39B₩26B₩41B
Borrowings₩65B₩48B₩36B₩34B₩30B₩27B₩31B₩43B
Total equity₩114B₩85B₩91B₩65B₩70B₩89B₩78B₩94B
Shareholders' equity₩114B₩85B₩91B₩65B₩70B₩89B₩78B₩94B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩3.8B−₩10B₩748M−₩3.4B−₩222M₩188M−₩764M−₩5B
Capital spending₩12B₩148M₩102M₩113M₩415M₩53M₩67M₩61M
Free cash flow−₩8.2B−₩10B₩646M−₩3.5B−₩638M₩135M−₩831M−₩5.1B

Consolidated where available. Amounts in won.

Also known as: Aribio Holdings / 아리바이오홀딩스 / 290690 / KRX:290690

Source: KRX statistical information